Read on Twitter
Kiss my ass Bill Gates!!!
--------------
Professor Gives Results of Hydroxychloroquine Treatment Study on 1061 Cases:
4/9/20
Key findings:
No cardiac toxicity observed.Â
A good clinical outcome & virological cure in 973 patients w/in 10 days (91.7%)Â
http://covexit.com/professor-didier-raoult-releases-the-results-of-a-new-hydroxychloroquine-treatment-study-on-1061-patients/#.XpOqkh51uFM.twitter
--------------
Professor Gives Results of Hydroxychloroquine Treatment Study on 1061 Cases:
4/9/20
Key findings:
No cardiac toxicity observed.Â
A good clinical outcome & virological cure in 973 patients w/in 10 days (91.7%)Â
http://covexit.com/professor-didier-raoult-releases-the-results-of-a-new-hydroxychloroquine-treatment-study-on-1061-patients/#.XpOqkh51uFM.twitter
The study was performed at IHU Méditerranée Infection, Marseille, France.
A cohort of 1061 COVID-19 patients, treated for at least 3 days with the (HCQ-AZ) combination and a follow-up of at least 9 days was investigated.
A cohort of 1061 COVID-19 patients, treated for at least 3 days with the (HCQ-AZ) combination and a follow-up of at least 9 days was investigated.
A poor outcome was observed for 46 patients (4.3%); 10 were transferred to intensive care units, 5 patients died (0.47%) (74-95 years old) and 31 required 10 days of hospitalization or more.
The authors conclude that:
“The HCQ-AZ combination, when started immediately after diagnosis, is a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagiosity in most cases.”
“The HCQ-AZ combination, when started immediately after diagnosis, is a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagiosity in most cases.”
